跳转至内容
Merck
所有图片(1)

文件

191523

Sigma-Aldrich

3,9-二乙烯基-2,4,8,10-四氧杂螺[5.5]十一烷

98%

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C11H16O4
CAS号:
78-19-3
分子量:
212.24
EC號碼:
201-092-7
MDL號碼:
MFCD00006564
分類程式碼代碼:
12352100
PubChem物質ID:
24851491
NACRES:
NA.22

化驗

98%

bp

108-110 °C/2 mmHg (lit.)

mp

43-46 °C (lit.)

密度

1.251 g/mL at 25 °C (lit.)

SMILES 字串

C=CC1OCC2(CO1)COC(OC2)C=C

InChI

1S/C11H16O4/c1-3-9-12-5-11(6-13-9)7-14-10(4-2)15-8-11/h3-4,9-10H,1-2,5-8H2

InChI 密鑰

OOXMQACSWCZQLX-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

應用

3,9-Divinyl-2,4,8,10-tetraoxaspiro[5.5]undecane is an acetal-type crosslinking agent comonomer and has been used:
  • in radical emulsion copolymerization of 2-hydroxyethyl methacrylate
  • as cross-linking agent in the synthesis of acid-degradable core-crosslinked micelles
  • in the synthesis of new biocompatible copolymer for loading the indomethacin as drug model

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 2

閃點（°F）

235.4 °F - closed cup

閃點（°C）

113 °C - closed cup

個人防護裝備

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Acid-Degradable Core-Crosslinked Micelles Prepared from Thermosensitive Glycopolymers Synthesized via RAFT Polymerization.
Zhang L, et al.
Macromolecular Rapid Communications, 29(2), 123-129 (2008)
Loredana E Nita et al.
Journal of materials science. Materials in medicine, 23(5), 1211-1223 (2012-03-15)
The study presents the possibility to use the 2-hydroxyethyl methacrylate--HEMA copolymer with a comonomer with spiroacetal moiety, 3,9-divinyl-2,4,8,10-tetraoxaspiro[5.5]-undecane)-U, as polymer network for loading the indomethacin--INN as drug model, and also, the controlled release evaluation of the prepared bioactive system. The
Upon the emulsion polymerization of 2-hydroxyethyl methacrylate with 3, 9-divinyl-2, 4, 8, 10-tetraoxaspiro [5.5]-undecane.
Nita LE, et al.
Colloids and Surfaces. A, Physicochemical and Engineering Aspects, 381(1), 111-117 (2011)
S Stern et al.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 41(2), 143-149 (1996-11-01)
Solid tumours contain hypoxic cells which are resistant to radiotherapy. This study compares the efficacy of several strategies to counteract diffusion-limited hypoxia, or intermittent hypoxia in a fractionated regimen of 1 to 6 x 2 Gy. Nicotinamide (250 mg/kg), perflubron

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门